{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03840343",
      "OrgStudyIdInfo": {
        "OrgStudyId": "18-002423"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "RMM 091718 CT 001",
            "SecondaryIdType": "Other Grant/Funding Number",
            "SecondaryIdDomain": "Regenerative Medicine Minnesota"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "Mayo Clinic",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease",
      "OfficialTitle": "Intra-arterially Delivered Autologous Mesenchymal Stem/Stromal Cell Therapy in Patients With Diabetic Kidney Disease: A Phase I Study"
    },
    "StatusModule": {
      "StatusVerifiedDate": "February 2021",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "October 23, 2019",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2024",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2025",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "February 11, 2019",
      "StudyFirstSubmitQCDate": "February 11, 2019",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "February 15, 2019",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "February 24, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "February 26, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "LaTonya J. Hickson",
        "ResponsiblePartyInvestigatorTitle": "Principal Investigator",
        "ResponsiblePartyInvestigatorAffiliation": "Mayo Clinic"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Mayo Clinic",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Regenerative Medicine Minnesota",
            "CollaboratorClass": "UNKNOWN"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes",
      "IsFDARegulatedDrug": "Yes",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The Researchers will assess the safety, tolerability, dosing effect, and early signals of efficacy of intra-arterially delivered autologous (from self) adipose (fat) tissue-derived mesenchymal stem/stromal cells (MSC) in patients with progressive diabetic kidney disease (DKD).",
      "DetailedDescription": "This is a single center, open-label dose-escalating study assessing safety, tolerability, dosing effect, and early signals of efficacy of intra-arterially delivered autologous (from self) adipose tissue-derived mesenchymal stem/stromal cells (MSC) in 30 patients with progressive diabetic kidney disease (DKD). DKD will be defined as chronic kidney disease (CKD; estimated glomerular filtration rate; eGFR<60 mL/min/1.73m2) in the setting of diabetes mellitus (type 2; on anti-diabetes therapy) without overt etiologies of CKD beyond concomitant hypertension. Progressive DKD will be considered as eGFR 25-55 ml/min/1.73m2 with a) eGFR decline of 5 ml/min over 18 months or 10 ml/min over 3 years or b) an intermediate or high 5-year risk of progression to end-stage kidney failure (dialysis or transplant) based on the validated Tangri 4-variable (age, sex, eGFR, urinary albumin-creatinine ratio) kidney failure risk equation. Fifteen subjects will be placed in one of two cell dosage arms in a parallel design with single-kidney MSC administration at Day 0 and Month 3. Subjects will be followed a total of 15 months from time of initial cell administration."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Diabetic Kidney Disease",
          "Diabetic Nephropathies",
          "Diabetes Mellitus, Type 2",
          "Diabetes Mellitus, Type 1",
          "Chronic Kidney Disease",
          "Diabetic Nephropathy Type 2",
          "Kidney Failure",
          "Kidney Insufficiency"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Mesenchymal Stem Cell",
          "Mesencymal Stromal Cell",
          "Stem Cell",
          "Regenerative Medicine",
          "Cell therapy",
          "Rejuvenation"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "30",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Lower Dose MSC",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "This arm will receive autologous adipose-derived Mesenchymal stem/stromal cells (MSC) Lower Dose.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose"
              ]
            }
          },
          {
            "ArmGroupLabel": "Higher Dose MSC",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "This arm will receive autologous adipose-derived Mesenchymal stem/stromal cells (MSC) Higher Dose",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose",
            "InterventionDescription": "Two MSC infusions of 2.5x10^5 cells/kg at time zero and three months; single kidney, intra-arterial delivery",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Lower Dose MSC"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose",
            "InterventionDescription": "Two MSC infusions of 5.0x10^5 cells/kg at time zero and three months; single kidney, intra-arterial delivery",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Higher Dose MSC"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Adverse Events",
            "PrimaryOutcomeDescription": "The number of Adverse Events associated with MSC intervention per treatment arm",
            "PrimaryOutcomeTimeFrame": "Baseline through Month 15"
          },
          {
            "PrimaryOutcomeMeasure": "Adverse Events",
            "PrimaryOutcomeDescription": "The percentage of Adverse Events associated with MSC intervention per treatment arm",
            "PrimaryOutcomeTimeFrame": "Baseline through Month 15"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Kidney Function",
            "SecondaryOutcomeDescription": "Change in measured glomerular filtration rate (mGFR). Measured as mL/min/BSA",
            "SecondaryOutcomeTimeFrame": "baseline, month 6"
          },
          {
            "SecondaryOutcomeMeasure": "Kidney Function",
            "SecondaryOutcomeDescription": "Change in estimated glomerular filtration rate (eGFR) slope. Measured as mL/min/1.73m^2/month",
            "SecondaryOutcomeTimeFrame": "pretreatment, month 12"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nDiabetes mellitus (on anti-diabetes drug therapy)\nAge 45-75 years\neGFR 25-55 ml/min/1.73m2 at time of consent with: a) eGFR decline of 5 ml/min over 18 months or 10 ml/min over 3 years or b) an intermediate or high 5-year risk of progression to end-stage kidney failure (dialysis or transplant) based on the validated Tangri 4-variable (age, sex, eGFR, urinary albumin-creatinine ratio) kidney failure risk equation https://kidneyfailurerisk.com/\nPrimary cause of kidney disease is diabetes without suspicion of concomitant kidney disease beyond hypertension\nSpot urine albumin:creatinine ≥30 mg/g unless on RAAS inhibition\nAbility to give informed consent\n\nExclusion Criteria:\n\nHemoglobin A1c≥11%\nPregnancy\nActive malignancy\nActive Immunosuppression therapy\nKidney transplantation history\nConcomitant glomerulonephritis\nNephrotic syndrome\nSolid organ transplantation history\nAutosomal dominant or recessive polycystic kidney disease\nKnown renovascular disease\nKidney failure (hemodialysis, peritoneal dialysis, or kidney transplantation)\nActive tobacco use\nBody weight >150 kg or BMI>50\nUncontrolled hypertension: Systolic blood pressure (SBP) >180 mmHg despite antihypertensive therapy\nRecent cardiovascular event (myocardial infarction, stroke, congestive heart failure within 6 months\nEvidence of hepatitis B or C, or HIV infection, chronic\nAnticoagulation therapy requiring heparin bridging for procedures.\nHistory of methicillin-resistant staphylococcus aureus colonization\nRecent plastic, chemical or surgical manipulation of adipose tissue for cosmetic purposes within 6 months\nInability to give informed consent\nPotentially unreliable subjects and those judged by the investigator to be unsuitable for the study",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "45 Years",
      "MaximumAge": "75 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "B Tietje",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "507-255-0401",
            "CentralContactEMail": "tietje.beverly@mayo.edu"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "LaTonya J Hickson, MD",
            "OverallOfficialAffiliation": "Mayo Clinic",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Mayo Clinic in Rochester",
            "LocationStatus": "Recruiting",
            "LocationCity": "Rochester",
            "LocationState": "Minnesota",
            "LocationZip": "55905",
            "LocationCountry": "United States",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "B Tietje",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "507-255-0401",
                  "LocationContactEMail": "tietje.beverly@mayo.edu"
                },
                {
                  "LocationContactName": "LaTonya J Hickson, MD",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "SeeAlsoLinkList": {
        "SeeAlsoLink": [
          {
            "SeeAlsoLinkLabel": "Diabetic Kidney Disease Stem Cell Trial - Mayo Clinic",
            "SeeAlsoLinkURL": "https://www.mayo.edu/research/clinical-trials/cls-20438442"
          },
          {
            "SeeAlsoLinkLabel": "Stem Cells and Kidney Disease - Mayo Clinic",
            "SeeAlsoLinkURL": "https://regenerativemedicineblog.mayoclinic.org/2018/10/26/stem-cells-and-chronic-kidney-disease/"
          },
          {
            "SeeAlsoLinkLabel": "Video of Stem Cell Trial in Diabetic Kidney Disease - Regenerative Medicine Minnesota",
            "SeeAlsoLinkURL": "https://youtu.be/DQ7r3UFMDN8"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000007674",
            "ConditionMeshTerm": "Kidney Diseases"
          },
          {
            "ConditionMeshId": "D000051436",
            "ConditionMeshTerm": "Renal Insufficiency, Chronic"
          },
          {
            "ConditionMeshId": "D000051437",
            "ConditionMeshTerm": "Renal Insufficiency"
          },
          {
            "ConditionMeshId": "D000003928",
            "ConditionMeshTerm": "Diabetic Nephropathies"
          },
          {
            "ConditionMeshId": "D000003920",
            "ConditionMeshTerm": "Diabetes Mellitus"
          },
          {
            "ConditionMeshId": "D000003924",
            "ConditionMeshTerm": "Diabetes Mellitus, Type 2"
          },
          {
            "ConditionMeshId": "D000003922",
            "ConditionMeshTerm": "Diabetes Mellitus, Type 1"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000044882",
            "ConditionAncestorTerm": "Glucose Metabolism Disorders"
          },
          {
            "ConditionAncestorId": "D000008659",
            "ConditionAncestorTerm": "Metabolic Diseases"
          },
          {
            "ConditionAncestorId": "D000004700",
            "ConditionAncestorTerm": "Endocrine System Diseases"
          },
          {
            "ConditionAncestorId": "D000014570",
            "ConditionAncestorTerm": "Urologic Diseases"
          },
          {
            "ConditionAncestorId": "D000001327",
            "ConditionAncestorTerm": "Autoimmune Diseases"
          },
          {
            "ConditionAncestorId": "D000007154",
            "ConditionAncestorTerm": "Immune System Diseases"
          },
          {
            "ConditionAncestorId": "D000048909",
            "ConditionAncestorTerm": "Diabetes Complications"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M6267",
            "ConditionBrowseLeafName": "Diabetes Mellitus",
            "ConditionBrowseLeafAsFound": "Diabetes Mellitus",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M6271",
            "ConditionBrowseLeafName": "Diabetes Mellitus, Type 2",
            "ConditionBrowseLeafAsFound": "Diabetes Mellitus, Type 2",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M25871",
            "ConditionBrowseLeafName": "Renal Insufficiency",
            "ConditionBrowseLeafAsFound": "Kidney Insufficiency",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M6269",
            "ConditionBrowseLeafName": "Diabetes Mellitus, Type 1",
            "ConditionBrowseLeafAsFound": "Diabetes Mellitus, Type 1",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9850",
            "ConditionBrowseLeafName": "Kidney Diseases",
            "ConditionBrowseLeafAsFound": "Kidney Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M6275",
            "ConditionBrowseLeafName": "Diabetic Nephropathies",
            "ConditionBrowseLeafAsFound": "Diabetic Nephropathy",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M25870",
            "ConditionBrowseLeafName": "Renal Insufficiency, Chronic",
            "ConditionBrowseLeafAsFound": "Chronic Kidney Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10791",
            "ConditionBrowseLeafName": "Metabolic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M24556",
            "ConditionBrowseLeafName": "Glucose Metabolism Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M7014",
            "ConditionBrowseLeafName": "Endocrine System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16471",
            "ConditionBrowseLeafName": "Urologic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3781",
            "ConditionBrowseLeafName": "Autoimmune Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9352",
            "ConditionBrowseLeafName": "Immune System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M25157",
            "ConditionBrowseLeafName": "Diabetes Complications",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC19",
            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BXS",
            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          }
        ]
      }
    }
  }
}